149 related articles for article (PubMed ID: 15390056)
1. Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene.
Capecci M; Passamonti L; Annesi F; Annesi G; Bellesi M; Candiano IC; Ricciuti R; Iacoangeli M; Scerrati M; Zappia M; Tarantino P; De Marco EV; Civitelli D; Carrideo S; Provinciali L; Ceravolo MG; Quattrone A
Mov Disord; 2004 Dec; 19(12):1450-2. PubMed ID: 15390056
[TBL] [Abstract][Full Text] [Related]
2. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
Kim JH; Chang WS; Jung HH; Chang JW
Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
[TBL] [Abstract][Full Text] [Related]
3. Are parkin patients particularly suited for deep-brain stimulation?
Lohmann E; Welter ML; Fraix V; Krack P; Lesage S; Laine S; Tanguy ML; Houeto JL; Mesnage V; Pollak P; Durr A; Agid Y; Brice A;
Mov Disord; 2008 Apr; 23(5):740-3. PubMed ID: 18228569
[TBL] [Abstract][Full Text] [Related]
4. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease.
Katayama Y; Oshima H; Kano T; Kobayashi K; Fukaya C; Yamamoto T
Stereotact Funct Neurosurg; 2006; 84(4):176-9. PubMed ID: 16905880
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
[TBL] [Abstract][Full Text] [Related]
6. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
9. Juvenile-onset parkinsonism with digenic parkin and PINK1 mutations treated with subthalamic nucleus stimulation at 45 years after disease onset.
Nakahara K; Ueda M; Yamada K; Koide T; Yoshimochi G; Funayama M; Kim JH; Yamakawa S; Mori A; Misumi Y; Uyama E; Hattori N; Ando Y
J Neurol Sci; 2014 Oct; 345(1-2):276-7. PubMed ID: 25106695
[No Abstract] [Full Text] [Related]
10. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
11. Direct relief of levodopa-induced dyskinesia by stimulation in the area above the subthalamic nucleus in a patient with Parkinson's disease--case report.
Nishikawa Y; Kobayashi K; Oshima H; Fukaya C; Yamamoto T; Katayama Y; Ogawa A; Ogasawara K
Neurol Med Chir (Tokyo); 2010; 50(3):257-9. PubMed ID: 20339282
[TBL] [Abstract][Full Text] [Related]
12. Benefits of subthalamic stimulation for elderly parkinsonian patients aged 70 years or older.
Chiou SM
Clin Neurol Neurosurg; 2016 Oct; 149():81-6. PubMed ID: 27494146
[TBL] [Abstract][Full Text] [Related]
13. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
14. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
16. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson's disease.
Alam M; Capelle HH; Schwabe K; Krauss JK
Brain Stimul; 2014; 7(1):13-20. PubMed ID: 24126192
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
18. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
[TBL] [Abstract][Full Text] [Related]
19. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
20. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
